INVO Fertility (IVF) Shareholder's Equity Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | INVO Fertility | 5.12 Mn | 4.76 Mn | 629,345.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 28.47% |
| Jun 30, 2025 | 22.26% |
| Mar 31, 2025 | 22.44% |
| Dec 31, 2024 | 40.28% |
| Sep 30, 2024 | 63.82% |
| Jun 30, 2024 | 19.45% |
| Mar 31, 2024 | 14.91% |
| Dec 31, 2023 | 18.41% |
| Sep 30, 2023 | 15.82% |
| Jun 30, 2023 | 16.23% |
| Mar 31, 2023 | 15.08% |
| Dec 31, 2022 | 27.83% |
| Sep 30, 2022 | 17.75% |
| Jun 30, 2022 | 21.96% |
| Mar 31, 2022 | 26.08% |
| Dec 31, 2021 | 29.08% |
| Sep 30, 2021 | 20.52% |
| Jun 30, 2021 | 25.03% |
| Mar 31, 2021 | 27.89% |
| Dec 31, 2020 | 28.68% |
| Sep 30, 2020 | 1.01% |
| Jun 30, 2020 | 2.29% |
| Mar 31, 2020 | 0.20% |
| Dec 31, 2019 | 3.15% |
| Sep 30, 2019 | 2.36% |
| Jun 30, 2019 | 5.17% |
| Mar 31, 2019 | 4.63% |
| Dec 31, 2018 | 6.51% |
| Sep 30, 2018 | -2.87% |
| Jun 30, 2018 | -2.49% |
| Mar 31, 2018 | -6.40% |
| Dec 31, 2017 | -8.16% |
| Sep 30, 2017 | -7.81% |
| Jun 30, 2017 | -8.98% |
| Mar 31, 2017 | -9.09% |
| Dec 31, 2016 | -9.56% |
| Sep 30, 2016 | -8.18% |
| Jun 30, 2016 | -7.30% |
| Dec 31, 2015 | -8.65% |